Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

This session examines the current state of progress toward a functional cure for HIV, drawing on advances in immunology, ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

And, if all goes well, over the next five years as well.

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific ...